Cargando…
Visual Genome-Wide RNAi Screening to Identify Human Host Factors Required for Trypanosoma cruzi Infection
The protozoan parasite Trypanosoma cruzi is the etiologic agent of Chagas disease, a neglected tropical infection that affects millions of people in the Americas. Current chemotherapy relies on only two drugs that have limited efficacy and considerable side effects. Therefore, the development of new...
Autores principales: | Genovesio, Auguste, Giardini, Miriam A., Kwon, Yong-Jun, Dossin, Fernando de Macedo, Choi, Seo Yeon, Kim, Nam Youl, Kim, Hi Chul, Jung, Sung Yong, Schenkman, Sergio, Almeida, Igor C., Emans, Neil, Freitas-Junior, Lucio H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098829/ https://www.ncbi.nlm.nih.gov/pubmed/21625474 http://dx.doi.org/10.1371/journal.pone.0019733 |
Ejemplares similares
-
Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development
por: Moraes, Carolina B., et al.
Publicado: (2014) -
High content cellular microarray for automated drug target deconvolution
por: Kwon, Yong-Jun, et al.
Publicado: (2011) -
A high-throughput cell-based assay to screen for drugs affecting PfEMP1 transport to RBC surface
por: Ku, Min-Je, et al.
Publicado: (2011) -
Novel structural CYP51 mutation in Trypanosoma cruzi associated with multidrug resistance to CYP51 inhibitors and reduced infectivity
por: Franco, Caio H., et al.
Publicado: (2020) -
Identification of Inhibitors to Trypanosoma cruzi Sirtuins Based on Compounds Developed to Human Enzymes
por: Matutino Bastos, Tanira, et al.
Publicado: (2020)